The US Healthcare Distribution Management Association, whose membership is composed of major pharmaceutical distributors, will be a key participant in a new FDA programme aimed at keeping counterfeit drugs out of the marketplace.
To aid the FDA effort, HDMA will lead a task force consisting of manufacturers, distributors, pharmacies, consumer groups and key trade associations to develop a comprehensive plan to implement various industry-wide technological solutions.
The task force will address packaging, labelling, overt and covert product marking and automated identification, including bar codes and RFID.